Genmab News

Genmab News

To comply with applicable regulation in Denmark, product-related media releases are removed from our website within three weeks of publication. They are available upon request. Please contact us here.

 

Feb 15, 2024 at 12:01 PM CET
Notice to Convene the Annual General Meeting of Genmab A/S
Download
Feb 14, 2024 at 8:10 PM CET
Genmab Files Annual Report with the U.S. Securities and Exchange Commission
Download
Feb 14, 2024 at 5:41 PM CET
Genmab Announces Initiation of Share Buy-Back Program
Download
Feb 14, 2024 at 5:02 PM CET
Genmab Publishes 2023 Annual Report
Download
Download
Jan 31, 2024 at 4:33 PM CET
Genmab A/S has published its Articles of Association
Download
Jan 25, 2024 at 8:22 PM CET
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Download
Jan 23, 2024 at 12:25 PM CET
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2023
Jan 23, 2024 at 12:41 AM CET
Genmab Announces Decision in Arbitration Appeal under License Agreement with Janssen
Download
Jan 3, 2024 at 6:56 AM CET
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
Download
Jan 2, 2024 at 3:53 PM CET
Genmab to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Download

  • Who we are

    Read about Genmab's purpose, core values and key accomplishments

    Learn more

  • Turning insights into medicine

    See the results of innovation that is rooted in science

    Explore the pipeline

  • Innovation for the future

    We are developing next-generation technologies

    See our technologies

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.

Continue

Back